e-learning
resources
Milan 2017
Monday, 11.09.2017
Management of Hospital-Acquired Pneumonia (HAP)/Ventilator-associated pneumonia (VAP)
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Epidemiology of HAP/VAP: The real burden
I. Martin-Loeches (Dublin 8, Ireland)
Source:
International Congress 2017 – Management of Hospital-Acquired Pneumonia (HAP)/Ventilator-associated pneumonia (VAP)
Session:
Management of Hospital-Acquired Pneumonia (HAP)/Ventilator-associated pneumonia (VAP)
Session type:
Session
Number:
1741
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Martin-Loeches (Dublin 8, Ireland). Epidemiology of HAP/VAP: The real burden. International Congress 2017 – Management of Hospital-Acquired Pneumonia (HAP)/Ventilator-associated pneumonia (VAP)
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Belief about cure of disease after dots
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
Are the Roma population risk group for tuberculosis?
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management III
Year: 2013
Differences in disease severity between combination treatments in a Swedish population
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Tuberculosis lineage in a low prevalence area; epidemiology and clinical characteristics
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013
The disease burden of mild asthma: Findings from a 2013 real world survey
Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality
Year: 2016
Epidemiology: development and perspectives
Source: Eur Respir Monogr 2015; 68: 1-11
Year: 2015
The global burden of pneumonia in China and the world: a Global Burden of Disease comparison
Source: International Congress 2019 – Chinese programme 2019: Part II
Year: 2019
Epidemiology and clinical features of nontuberculous mycobacterial lung disease in a subtropical region in Japan: Analysis with a 7-year data in two major hospitals
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
The causes of death among patients with tuberculosis
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015
Risk factors for pulmonary tuberculosis in Croatia
Source: Annual Congress 2013 –Tuberculosis: clinical epidemiology and public health
Year: 2013
Epidemiology of communicable diseases: tuberculosis
Source: Online Course 2014 - Respiratory epidemiology
Year: 2014
Estimating severe asthma prevalence in austria using nationwide prescription data
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Productivity losses in COPD – A population-based survey.
Source: International Congress 2014 – Lung function, COPD and inflammation
Year: 2014
LATE-BREAKING ABSTRACT: The effectiveness of clinical Influenza diagnosis in a Belgian out-patient setting identifies the need for rapid diagnostic assays
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
A novel score of respiratory health predicts hospitalizations in children
Source: International Congress 2014 – Emerging concepts in respiratory disease
Year: 2014
Risk factors for tuberculosis relapse in Polish patients
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Epidemiology
Source: Eur Respir Monogr 2016; 71: 1-15
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept